ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - dexamethasone - שתל במתקן להחדרת תרופה - dexamethasone 0.7 mg - dexamethasone - dexamethasone - ozurdex is indicated for the treatment of adult patients with macular edema following either branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo).ozurdex is indicated for the treatment of adult patients with inflammation of the posterior segment of the eye presenting as non-infectious uveitis.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - ofloxacin - תמיסה לעין - ofloxacin 0.3 % - ofloxacin - ofloxacin - for the treatment of external ocular infections caused by ofloxacin sensitive organisms.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - prednisolone acetate - תרחיף לעין - prednisolone acetate 1 %w/v - prednisolone - prednisolone - for steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - fluorometholone - תרחיף לעין - fluorometholone 0.1 %w/v - fluorometholone - fluorometholone - to treat eye inflammation.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - brimonidine tartrate - תמיסה לעין - brimonidine tartrate 0.15 %w/v - brimonidine - brimonidine - alphagan is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - brimonidine tartrate; timolol as maleate - תמיסה לעין - timolol as maleate 0.5 %w/v; brimonidine tartrate 0.2 %w/v - brimonidine - brimonidine - combigan is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - bimatoprost; timolol as maleate - טיפות עיניים - bimatoprost 0.3 mg/ml; timolol as maleate 5 mg/ml - timolol - timolol - reduction of intraocular pressure in patients with open- angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - epinastine hydrochloride - תמיסה לעין - epinastine hydrochloride 0.05 %w/v - epinastine - epinastine - treatment of the symptoms of seasonal allergic conjunctivitis.

ישראל - עברית - Ministry of Health

omrix biopharmaceuticals ltd, israel - human immunoglobulin - תמיסה להזרקה - human immunoglobulin 5 g / 100 ml - specific immunoglobulins - passive immunization for the prevention of hepatitis b virus re-infection after liver transplantation.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - adalimumab 40 mg / 0.8 ml - solution for injection - pfs - adalimumab - * rheumatoid arthritis: humira in combination with methotrexate is indicated for: - the treatment of moderate to severe active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate. - the treatment of severe active and progressive rheumatoid arthritis in adults not previously treated with methotrexate. humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. humira has been shown to reduce the rate of progression of joint damage as measured by x-ray adn to impove physical function when given in combination with methotrexate. * crohn's disease : humira is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active crohn's disease who have had an inadequate response to conventional therapy.humira is indicated for reducing signs and symptoms and inducing clinical r